 Mark Kearns
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 4 | 2014 | 357 | 0.790 |
Why?
| | Apoptosis | 3 | 2014 | 2377 | 0.510 |
Why?
| | Fas Ligand Protein | 1 | 2014 | 59 | 0.470 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 68 | 0.390 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2012 | 57 | 0.390 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 503 | 0.330 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2014 | 693 | 0.330 |
Why?
| | Pneumonia | 1 | 2014 | 576 | 0.320 |
Why?
| | Lung | 3 | 2014 | 3673 | 0.250 |
Why?
| | Patient Positioning | 1 | 2021 | 43 | 0.180 |
Why?
| | Acute Lung Injury | 2 | 2014 | 300 | 0.170 |
Why?
| | Mice, Transgenic | 3 | 2014 | 1970 | 0.170 |
Why?
| | Social Determinants of Health | 1 | 2021 | 136 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2015 | 4773 | 0.160 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 292 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2021 | 526 | 0.140 |
Why?
| | Schistosomiasis mansoni | 1 | 2015 | 19 | 0.130 |
Why?
| | Interleukin-13 | 1 | 2015 | 126 | 0.120 |
Why?
| | Interleukin-4 | 1 | 2015 | 209 | 0.120 |
Why?
| | Curriculum | 1 | 2021 | 853 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2014 | 608 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2014 | 199 | 0.110 |
Why?
| | Endothelial Progenitor Cells | 1 | 2013 | 19 | 0.110 |
Why?
| | Bone Marrow Transplantation | 2 | 2015 | 239 | 0.110 |
Why?
| | Neovascularization, Physiologic | 1 | 2014 | 174 | 0.110 |
Why?
| | Regeneration | 1 | 2014 | 162 | 0.110 |
Why?
| | Jurkat Cells | 1 | 2012 | 128 | 0.100 |
Why?
| | Doxycycline | 1 | 2012 | 56 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 951 | 0.100 |
Why?
| | Mice | 5 | 2015 | 15052 | 0.100 |
Why?
| | fas Receptor | 1 | 2011 | 93 | 0.090 |
Why?
| | Pyrroles | 1 | 2012 | 185 | 0.090 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 826 | 0.090 |
Why?
| | Emphysema | 1 | 2012 | 124 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 346 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 465 | 0.090 |
Why?
| | Pulmonary Emphysema | 1 | 2013 | 316 | 0.090 |
Why?
| | Radiation Injuries, Experimental | 1 | 2010 | 25 | 0.090 |
Why?
| | Gamma Rays | 1 | 2010 | 47 | 0.090 |
Why?
| | Whole-Body Irradiation | 1 | 2010 | 72 | 0.090 |
Why?
| | Indoles | 1 | 2012 | 309 | 0.080 |
Why?
| | Macrophages | 1 | 2015 | 1284 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 965 | 0.080 |
Why?
| | Lung Injury | 1 | 2010 | 199 | 0.070 |
Why?
| | Animals | 6 | 2015 | 32102 | 0.070 |
Why?
| | Cell Line | 1 | 2012 | 2651 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2578 | 0.070 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1265 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1098 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2015 | 1749 | 0.060 |
Why?
| | Prone Position | 1 | 2021 | 27 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2014 | 1083 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 414 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 376 | 0.040 |
Why?
| | Critical Care | 1 | 2021 | 477 | 0.040 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 7 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 2015 | 22 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2015 | 41 | 0.030 |
Why?
| | Smad2 Protein | 1 | 2015 | 33 | 0.030 |
Why?
| | Schistosoma mansoni | 1 | 2015 | 33 | 0.030 |
Why?
| | Th17 Cells | 1 | 2015 | 59 | 0.030 |
Why?
| | Th1 Cells | 1 | 2015 | 125 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 168 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2015 | 151 | 0.030 |
Why?
| | AC133 Antigen | 1 | 2013 | 20 | 0.030 |
Why?
| | Endothelium | 1 | 2014 | 115 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 90 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2015 | 350 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 76 | 0.030 |
Why?
| | Humans | 5 | 2021 | 115613 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 2013 | 90 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 88 | 0.030 |
Why?
| | Cell Count | 1 | 2013 | 305 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 446 | 0.030 |
Why?
| | Bleomycin | 1 | 2014 | 232 | 0.030 |
Why?
| | Vital Capacity | 1 | 2013 | 277 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 516 | 0.030 |
Why?
| | Glycoproteins | 1 | 2013 | 309 | 0.020 |
Why?
| | Caspase 8 | 1 | 2011 | 43 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1571 | 0.020 |
Why?
| | Antigens, CD | 1 | 2013 | 442 | 0.020 |
Why?
| | Radiation Chimera | 1 | 2010 | 31 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2010 | 95 | 0.020 |
Why?
| | Aged | 2 | 2021 | 19255 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 2604 | 0.020 |
Why?
| | Female | 4 | 2021 | 59932 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 397 | 0.020 |
Why?
| | Peptides | 1 | 2013 | 864 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 27014 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1642 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 3914 | 0.020 |
Why?
| | Male | 3 | 2021 | 55968 | 0.020 |
Why?
| | Inflammation | 1 | 2015 | 2500 | 0.020 |
Why?
| | United States | 1 | 2021 | 12297 | 0.020 |
Why?
| | Neutrophils | 1 | 2010 | 1172 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 12608 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 3580 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6165 | 0.010 |
Why?
| | Adult | 1 | 2021 | 30726 | 0.010 |
Why?
|
|
Kearns's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|